BRAIN Biotech AG (LON: 0RFI)
London
· Delayed Price · Currency is GBP · Price in EUR 3.270
+0.100 (3.15%)
At close: Jan 21, 2025
BRAIN Biotech AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Net Income | -11.13 | -11.13 | -8.28 | -6.59 | -4.97 | -9.68 | Upgrade
|
| Depreciation & Amortization | 4.82 | 4.82 | 4.65 | 4.34 | 4.01 | 3.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | -0 | -0.03 | 0.01 | 0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.53 | -2.36 | -0.58 | 0.16 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.5 | 0.5 | 1.49 | 2.43 | 1.72 | 2.39 | Upgrade
|
| Stock-Based Compensation | 0.89 | 0.89 | 0.8 | 0.75 | 0.51 | 0.45 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 0 | -0.02 | 0 | -0 | 0.09 | Upgrade
|
| Other Operating Activities | -4.11 | -4.11 | -2.47 | -3.66 | -5.96 | -3.86 | Upgrade
|
| Change in Accounts Receivable | 1.8 | 1.8 | -1.33 | -0.23 | -0.14 | 0.06 | Upgrade
|
| Change in Inventory | 0.41 | 0.41 | -0.04 | -2.41 | -0.02 | 0.73 | Upgrade
|
| Change in Accounts Payable | -0.11 | -0.11 | -1.17 | 2.53 | 0.31 | -1.26 | Upgrade
|
| Change in Unearned Revenue | 2.36 | 2.36 | 3.49 | 2.51 | 1.72 | 1.26 | Upgrade
|
| Change in Other Net Operating Assets | 1.11 | 1.11 | -0.62 | 1.24 | -0.4 | 1.06 | Upgrade
|
| Operating Cash Flow | -3.58 | -3.58 | -4.22 | -1.49 | -3.91 | -4.77 | Upgrade
|
| Capital Expenditures | -1.55 | -1.55 | -2.62 | -5.8 | -1.25 | -2.82 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.18 | 0.14 | 0 | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -3.1 | -0.44 | - | Upgrade
|
| Divestitures | - | - | 3.04 | -1.07 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.18 | -0.18 | -0.02 | -0.28 | -0.01 | -0.04 | Upgrade
|
| Investment in Securities | - | - | -0.11 | -1.17 | -0.56 | -1.87 | Upgrade
|
| Other Investing Activities | 0.02 | 0.02 | 0.09 | -1.4 | 0.08 | 0.24 | Upgrade
|
| Investing Cash Flow | -1.69 | -1.69 | 0.56 | -12.69 | -2.18 | -4.47 | Upgrade
|
| Long-Term Debt Issued | 31.87 | 31.87 | 13 | 0.35 | 0.06 | 1.25 | Upgrade
|
| Long-Term Debt Repaid | -5.48 | -5.48 | -2.96 | -2.32 | -2.88 | -2.73 | Upgrade
|
| Net Debt Issued (Repaid) | 26.39 | 26.39 | 10.05 | -1.97 | -2.82 | -1.48 | Upgrade
|
| Issuance of Common Stock | 0.6 | 0.6 | - | - | 18.98 | 14.57 | Upgrade
|
| Other Financing Activities | - | - | -9.59 | - | -4.59 | -0 | Upgrade
|
| Financing Cash Flow | 26.99 | 26.99 | 0.46 | -1.97 | 11.57 | 13.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.1 | 0.1 | 0.11 | 0.04 | 0.12 | -0.07 | Upgrade
|
| Net Cash Flow | 21.82 | 21.82 | -3.09 | -16.1 | 5.6 | 3.78 | Upgrade
|
| Free Cash Flow | -5.14 | -5.14 | -6.84 | -7.29 | -5.16 | -7.59 | Upgrade
|
| Free Cash Flow Margin | -9.25% | -9.25% | -12.16% | -14.48% | -13.15% | -19.42% | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -0.24 | -0.31 | -0.33 | -0.26 | -0.41 | Upgrade
|
| Cash Interest Paid | 1.64 | 1.64 | 0.78 | 0.5 | 0.43 | 0.49 | Upgrade
|
| Cash Income Tax Paid | 0.04 | 0.04 | 0.2 | 0.26 | 0.33 | -0.04 | Upgrade
|
| Levered Free Cash Flow | 1.03 | 1.03 | -4.39 | -2.36 | -2.64 | -4.19 | Upgrade
|
| Unlevered Free Cash Flow | 2.24 | 2.24 | -3.86 | -2.03 | -2.31 | -3.77 | Upgrade
|
| Change in Net Working Capital | -3.89 | -3.89 | 3.11 | -2.32 | 1.43 | 1.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.